KIR2DL3 and infection: The protective role of KIR2DL3 has been highlighted in various clinical profiles following exposure to HCV virus, confirming its positive impact on different subgroups: those who show resistance to HCV infection once contracted, those who resolve the infection spontaneously, and those who respond to chronic treatment with IFN-α [268].